Brief: Axsome Therapeutics Q2 Net Income USD -51.314 Million
10/08/2026 12:01
BRIEF-Axsome Therapeutics Q2 Net Income USD -51.314 Million Aug 10 (Reuters) - Axsome Therapeutics Q2 pretax profit USD -51.186 million.
- Q2 operating income USD -49.646 million
- Q2 operating expenses USD 268.021 million
Recent news on Axsome Therapeutics
See all newsUS RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation
Axsome Therapeutics Q3 revenue rises on Auvelity and Sunosi
US RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Axsome Therapeutics Q2 revenue rises on AUVELITY growth